Certain Co-Promotion Terms Sample Clauses

Certain Co-Promotion Terms. Commercialization The Commercialization Plan will include (a) a multi-year marketing strategy, (b) a multi-year communications strategy, (c) a multi-year detailing strategy (including, without limitation, a call plan which shall consist of a high-level geographic distribution of details, a target range of the aggregate number of details to be performed and the position of such details (i.e., primary or secondary)), and (d) a high-level operating plan and budget for Commercialization of the Product. The numbers in contemplating the initial Commercialization Plan are as follows: 12-month period prior to launch --$[*] First 12-month period after launch --$[*] (such 12-month period and each successive 12-month period thereafter, a “launch year”) 2nd launch year--$[*] 3rd launch year--$[*] 4th launch year--$[*] [*] = Certain confidential information contained in this document, marked by brackets, has been omitted because it is both (i) not material and (ii) would likely cause competitive harm to the company if publicly disclosed. Teams and responsibilities 1. AstraZeneca will hire, train, and manage the marketing team in accordance with budget and activities set forth in the Commercialization Plan. 2. AstraZeneca will hire, train, and manage the national sales team to cover all target hospitals, affiliated or independent dialysis centers, and physicians according to the Commercialization Plan. If AstraZeneca desires to utilize an external sales force to detail the Products, then it shall discuss such utilization with the China Committee. AstraZeneca shall not utilize any such external sales force without the approval of FibroGen China, and FibroGen China shall not utilize any external sales force without the approval of AstraZeneca, in either case, such approval not to be unreasonably withheld. Any such sales force will be required to agree in writing to meet all of the quality, ethical and compliance standards undertaken by AstraZeneca or FibroGen China (as the case may be, including, but not limited to, all of AstraZeneca’s policies regarding engagement of health care professionals), and shall not have been found to have committed a material violation of any rule or regulation of the CFDA. 3. FibroGen China will hire, train, and manage brand physicians and the Medical Science Liaison (MSL) team to conduct medical affairs activities according to the Development Plan and to provide scientific support for the Sales and Marketing teams in the Territory according ...